| Term 
 | Definition 
 
        | Tx: HTN first choice drug!, edema, CHF, hypocalcemia, diabetes insipidus Ax: Thiazide diuretic - inital phase: ↑Na+ loss, ↓plasma volume, ↓CO, Chronic Phase:
 ↓Peripheral vascular resistance SE: Hypokalemia→U wave+long QT→vent. arrhythmias Ms: countermeasures - K+-sparing diuretic, K+ supplements, or combo w/ ACE-I/ARBs     |  | 
        |  | 
        
        | Term 
 
        | 
 Verapamil  Diltiazem Nifedipine   |  | Definition 
 
        | Tx: HTN (esp for pts w/ angina), ischemic heart disease, arrhythmias (slow AV) Ax: Ca2+ Channel Blockers - directly inhibit L-type Ca2+ channels,
 ↓Ca2+ influx into mm cells (vascular, cardiomyocytes), ↓periph vascular resistance SE: verapamil (9%) & diltiazem: AV Block, Bradycardia, CHF, nausea; nifedipine (17%): ankle edema, hypotension, tinnitus Ms: Type I (V&D): "balanced" heart & vasc. effects Type II (N): mainly vasc. effects (↓PVR) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tx: HTN- okay alone, but better in combo therapies Ax: Nonpeptide Renin inhibitor - specific renin inhibitor, dose-dependent effects, possibly more complete inhib of renin-angio-aldost system Ms: no kinin meta.→no cough or angioneurotic edema t½=20-45hrs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tx: HTN in pts w/ comorbidities (CHF, CAD, chronic renal disease EXCEPT renal artery stenosis) Ax: ACE-Inhibitor - ↓angiotensin II, ↓aldost, ↑renin, ↑bradykinin (PGs vasodiolation), ↓BP + heart remodeling SE: risk of renal failure in pts w./ renal art. stenosis (massive ↓renal urine flow), cough (5-20%, due to bradykinin), angioneurotic edema, teratogenic, hyperkalemia   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tx: HTN - can use in pts with cough or angioneurotic edema w/ ACE-I Ax: ARB (AII R Antag.), competitive AT1 inhib., dose-dependent ↓ in periph vascular resistance, more complete inhibition of renin-angio-aldost system SE: risk of renal failure in pts w/ renal art. stenosis, teratogenic, hyperkalemia Ms: no ↑ kinin levels, 10,000x higher affinity for AT1 than AT2 |  | 
        |  |